Inverna Therapeutics announces the formation of its Scientific Advisory Board consisting of world-renowned leaders in RNA therapeutics and neurodegenerative research
The grant will support development of Inverna’s novel RNA therapy…
Precision RNA splicing modulation
Inverna Therapeutics is dedicated to the development of an RNA therapeutics platform to modify RNA expression with unparalleled specificity. Leveraging sequence-specific activation of pseudo exons, we develop safer, more effective precision medicines for unmet medical needs.
Transforming RNA discovery into therapy
Inverna is pioneering RNA therapeutics with its proprietary pseudo-exon activation platform. By precisely modulating splicing, we control how genes are expressed, ultimately adjusting the expression of specific proteins to target disease at its source.
Meet the team advancing RNA therapeutics
Behind Inverna is a team of scientists, innovators, and industry leaders dedicated to turning cutting-edge RNA research into real-world therapies.
Latest news
Inverna Therapeutics awarded grant from the Michael J. Fox Foundation for Parkinson’s research
The grant will support development of Inverna’s novel RNA therapy…
Inverna Therapeutics will participate in BIO-Europe 2025
We are excited to participate in BIO-Europe 2025 and are…